New device aims to make blood cancer tests more reliable
NCT ID NCT05942066
Summary
This study is testing a new blood processing device called See.d to help standardize liquid biopsy tests. Liquid biopsies are blood tests that can detect cancer cells or DNA. Researchers will collect blood samples from 200 healthy volunteers to see if the device produces consistent, high-quality samples for analysis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
Contact
Conditions
Explore the condition pages connected to this study.